China Healthwise Holdings Limited provided earnings guidance for the six months ended 30 September 2019. The board of directors of the Company (the "Board") wishes to inform the shareholders of the company (the "Shareholders") and potential investors that, based on the preliminary assessment of the unaudited consolidated management accounts of the Group for the six months ended 30 September 2019, the Group expects to record a significant increase in loss attributable to equity holders of the Company as compared to a loss attributable to equity holders of the Company of HKD 39.1 million for the six months ended 30 September 2018. The expected increase in loss is mainly due to significant increase in segment losses of investment in financial instruments to approximately HKD 54 million for the six months ended 30 September 2019; and partially offset by the absence of the previous period's segment loss of the original equipment manufacturing (OEM) toy business of approximately HKD 20 million which have been disposed of in January 2019.